Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

One Week Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study With Creon® 25000 Minimicrospheres™ in Subjects With Pancreatic Exocrine Insufficiency After Pancreatic Surgery, Followed by an Open-Label Long-Term Extension of 1 Year

NCT00535756 is registered in ClinicalTrials.gov with Abbott Products as lead sponsor.

NCT NCT00535756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00535756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
One Week Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multi-Center Study With Creon® 25000 Minimicrospheres™ in Subjects With Pancreatic Exocrine Insufficiency After Pancreatic Surgery, Followed by an Open-Label Long-Term Extension of 1 Year
Lead sponsor
Abbott Products
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2008
Completion date
June 30, 2011
Enrollment
58 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatic insufficiency